NCT01870284 Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) Status WITHDRAWN Phase PHASE3
NCT01867307 Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls Status COMPLETED Phase PHASE2
NCT01867216 A Study of Multiple Doses of LY2922470 in Participants With Diabetes Status COMPLETED Phase PHASE1
NCT01859078 A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01855919 A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain Status COMPLETED Phase PHASE3
NCT01845077 Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets Status COMPLETED Phase PHASE1
NCT01837641 A Study of LY3002813 in Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01836575 Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 Status COMPLETED Phase PHASE3
NCT01836198 The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream Status COMPLETED Phase PHASE1
NCT01836185 A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment Status COMPLETED Phase PHASE1
NCT01825889 A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants Status COMPLETED Phase PHASE1
NCT01825876 A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01824290 A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE3
NCT01821703 A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants Status COMPLETED Phase PHASE1